(20371917), S. K. (2025). Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells.
Chicago Style aipamena(20371917), Sushil Kumar. Supplementary Figure 5: Pathway Analysis After Treatment with KC and KCM Serum in Precursor Cells. 2025.
MLA aipamena(20371917), Sushil Kumar. Supplementary Figure 5: Pathway Analysis After Treatment with KC and KCM Serum in Precursor Cells. 2025.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.